175 related articles for article (PubMed ID: 18254710)
1. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls.
Goulas A; Kosmidou M; Hatzitolios AI; Raikos N; Molyva D; Savopoulos C; Giannopoulos S; Fidani L
Clin Chem Lab Med; 2008; 46(3):306-10. PubMed ID: 18254710
[TBL] [Abstract][Full Text] [Related]
2. An association study between catalase -262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls.
Kosmidou M; Hatzitolios AI; Molyva D; Raikos N; Savopoulos C; Daferera N; Kokkas V; Goulas A
Free Radic Res; 2009 Apr; 43(4):385-9. PubMed ID: 19274593
[TBL] [Abstract][Full Text] [Related]
3. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease.
Uzunoğlu S; Acar H; Okudan N; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Jan; 297(7):289-93. PubMed ID: 16283344
[TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
6. The association between glutathione S-transferase T1 and M1 gene polymorphisms and cardiovascular autonomic neuropathy in Slovak adolescents with type 1 diabetes mellitus.
Vojtková J; Ďurdík P; Čiljaková M; Michnová Z; Turčan T; Babušíková E
J Diabetes Complications; 2013; 27(1):44-8. PubMed ID: 23021798
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase M1 and T1 polymorphisms in Turkish patients with varicocele.
Acar H; Kılınç M; Guven S; Inan Z
Andrologia; 2012 Feb; 44(1):34-7. PubMed ID: 21488930
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
Siebers RW; Maling TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
[TBL] [Abstract][Full Text] [Related]
9. Relationship between sodium-lithium countertransport and insulin sensitivity in mild hypertension.
Herlitz H; Landin K; Widgren B
J Intern Med; 1996 Mar; 239(3):235-40. PubMed ID: 8772622
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between glutathione S-transferase M1, T1 genotype and susceptibility to gastric cancer].
Cai L; Yu S; Chen J
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):331-3. PubMed ID: 11864501
[TBL] [Abstract][Full Text] [Related]
11. The role of glutathione S-transferase M1 and T1 gene polymorphisms and fruit and vegetable consumption in antioxidant parameters in healthy subjects.
Yuan LH; Meng LP; Ma WW; Li S; Feng JF; Yu HL; Xiao R
Br J Nutr; 2012 Mar; 107(6):928-33. PubMed ID: 21896242
[TBL] [Abstract][Full Text] [Related]
12. Association between glutathione S-transferase M1 polymorphism and urinary sodium excretion in a Brazilian population.
Schreiber R; Mill JG; Krieger JE; Pereira AC; Nadruz W
Am J Hypertens; 2013 Aug; 26(8):1024-9. PubMed ID: 23690164
[TBL] [Abstract][Full Text] [Related]
13. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
[TBL] [Abstract][Full Text] [Related]
14. Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.
Simon T; Becquemont L; Mary-Krause M; de Waziers I; Beaune P; Funck-Brentano C; Jaillon P
Clin Pharmacol Ther; 2000 Apr; 67(4):432-7. PubMed ID: 10801254
[TBL] [Abstract][Full Text] [Related]
15. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension.
Mead P; Wilkinson R; Thomas TH
Hypertension; 1999 Dec; 34(6):1275-80. PubMed ID: 10601130
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
17. Na-Li countertransport kinetics in the relatives of hypertensive patients with abnormal Na-Li countertransport activity.
Rutherford PA; Thomas TH; Wilkinson R
Biochem Mol Med; 1997 Oct; 62(1):106-12. PubMed ID: 9367806
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study.
Weder AB; Delgado MC; Zhu X; Gleiberman L; Kan D; Chakravarti A
Hypertension; 2003 Mar; 41(3 Pt 2):842-6. PubMed ID: 12624006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
